发明名称 PYRAZOLONES
摘要 Pyrazolone derivatives represented by general formula (I) or salts thereof which have antiplatelet aggregation effects and thus are useful as a preventive or remedy for various thrombotic diseases. In said formula (I) X1 and X2 represents (a), wherein A represents cyano, cyano(C1-4 alkyl), amino, amino-(C1-4 alkyl), amidino, guanidino, etc.; and R1 and R2 independently represents each hydrogen, halogeno, C1-6 alkyl, etc.; another of X1 and X2 represents C1-6 alkyl, C3-6 alkenyl, aryl(C1-4 alkyl) or aryl; one of Y1 and Y2 represents (b), wherein Q represents oxygen or sulfur; Z1 represents oxygen, -NR7- or -CHR7-; Z2 represents cyclic C3-7 alkylene, C1-3 alkylene, CH2CO-, -CH2CH2CO-, etc.; Z3 represents oxygen, sulfur, sulfinyl, sulfonyl, etc.; Z4 represents C1-3 alkylene, etc.; and Z5 represents carboxyl, etc.; and another of Y1 and Y2 represents D-E-, wherein E represents a bond, C1-4 alkylene, phenylene, etc.; and D represents hydrogen, C1-6 alkyl, etc.
申请公布号 CA2234560(A1) 申请公布日期 1997.04.17
申请号 CA19962234560 申请日期 1996.10.11
申请人 NISSAN CHEMICAL INDUSTRIES, LTD. 发明人 TANIKAWA, KEIZO;MATSUMOTO, TAKASHI;ASADA, YASUNORI;NAKAMURA, MASUMI;SHUDO, NORIMASA
分类号 A61K31/415;A61K31/44;A61K31/4427;A61K31/445;A61K31/47;A61K31/495;A61P7/02;A61P9/08;A61P9/10;C07D231/12;C07D231/14;C07D231/20;C07D231/22;C07D401/04;C07D401/06;C07D401/14;C07D403/04;C07D403/06;(IPC1-7):C07D231/22;C07D403/14;A61K31/55;C07F9/650;A61K31/675 主分类号 A61K31/415
代理机构 代理人
主权项
地址